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SMALL NON-CODING RNA CAN TRANSFER THROUGH
THE PLACENTA AND REGULATE FETAL DEVELOPMENT
Increasing evidence demonstrated that exogenous plant
miRNAs in the diet can be absorbed and are found in
mammalian tissues. These miRNAs inﬂuence the physio-
logical and pathological progression of the recipient. In this
issue, Jing Li and colleagues further reveal that exogenous/
endogenous small non-coding RNA in the maternal system
can transfer through the placenta to the fetal side and inﬂu-
ence fetal development and health. These surprising ﬁnding
demonstrate that maternal miRNAs proﬁling are very impor-
tant to fetal development, which means maternal diet and
the healthy status may inﬂuence fetal development and the
postnatal morbidity via transplacental small non-coding RNAs.
Furthermore, this ﬁnding also proposes a brand new potential
strategy to treat fetal diseases in utero. Combining with gene
therapy, maternal administrating represents a new trend for
treating fetal diseases.
—Yali Hiu1
The placenta is a vital organ on which the survival and
growth of the fetus are critically dependent. It forms the in-
terface between the maternal and fetal environments, fa-
cilitates the exchange of gases, nutrients, and waste
products between the mother and baby and also acts as a
barrier against the maternal immune system (Watson and
Cross, 2005). In humans and rodents, the overall structures
and the molecular mechanisms of placental development
are thought to be quite similar; thus, the mouse is commonly
used as a model to study the placenta. In mice, placental
development begins at embryonic day (E) 3.5, and the pla-
centa is considered mature at E 14.5 (Rossant and Cross,
2001). Nutrients are transferred through the placenta via
three mechanisms: passive diffusion, facilitated diffusion,
and active transport (van der Aa et al., 1998).
MiRNAs are steadily present in the circulatory system and
can serve as biomarkers for cancers and other diseases
(Chen et al., 2008). These plasma miRNAs are actively se-
creted from tissues and are mainly packaged by microvesi-
cles (MVs), which will then deliver these miRNAs and
facilitate their entry into distance recipient tissues to regulate
gene expression (Zhang et al., 2010). Further study revealed
that exogenous plant MIR168 in food can be absorbed by
the mammalian small intestine and is present in animal
plasma. Exogenous plasma MIR168 then enters the liver
and regulates the target gene low-density lipoprotein (LDL)
receptor adapter protein 1 (LDLRAP1), showing that ex-
ogenous plant miRNAs play an important role in regulating
physiological and pathological progression (Zhang et al.,
2012).
In the present study, we were surprised to ﬁnd exogenous
plant miRNAs in human umbilical cord blood and amniotic
ﬂuid. Thus, based upon these ﬁndings, we propose the hy-
pothesis that endogenous/exogenous small non-coding
RNAs, including miRNAs and siRNAs, can transfer through
the placenta and enter the fetus to regulate fetal
development.
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Upon detecting the global miRNA expression proﬁle in the
umbilical cord blood and amniotic ﬂuid of healthy Chinese
pregnant women, we found that exogenous plant miRNAs
were consistently present in human umbilical cord blood and
amniotic ﬂuid, which belongs to the fetal circulation system
(Fig. 1A and Table S1A). The presence of plant miRNAs in
fetal umbilical cord blood and amniotic ﬂuid suggests that
exogenous miRNAs could transfer through the placenta to
the fetal side. Plant miRNAs were also found in the mouse
fetuses by quantitative RT-PCR (Fig. 1B). Taken together,
the above results suggest that miRNA may transfer through
the placenta to the fetal side.
To further investigate whether mature miRNAs can pass
through the placenta, an exogenous mature miRNA
originated from the inﬂuenza virus was employed to trace the
miRNA in mice. We synthesised mature miRNAs of the in-
ﬂuenza virus and gavage fed these miRNAs to pregnant
mice that had been pregnant for at least 14 days and had
mature placenta. The level of the inﬂuenza virus miRNAs in
maternal plasma were elevated signiﬁcantly 3 h after gavage
feeding (Fig. 1C). In the fetal liver, we also observed an
increase in the exogenous miRNA level (Fig. 1D).
Next, we sought to further investigate whether mature
miRNAs in plants can pass through the placenta and efﬁ-
ciently enter fetal organs. Honeysuckle (HS) is a famous
traditional Chinese herb. It was chosen because of the
speciﬁc enrichment of MIR2911. Thus, MIR2911 can serve
as a tool to trace the transplacental transmission of exoge-
nous plant miRNAs. According to our previous study,
MIR2911 is hardly degraded during boiling, so it is stably
present in the HS decoction (Zhou et al., 2015). The mice
were gavage fed with 0.5 mL HS decoction, and the ma-
ternal plasma and fetal liver were collected 3 h after gavage
feeding. Precautions were taken to prevent contamination of
the fetus with the maternal sample. The results revealed that
the MIR2911 levels were elevated ∼3.5-fold in the maternal
plasma, reaching 180 fM (Fig. 1E). The MIR2911 level also
increased in the placenta (Fig. 1F). Interestingly, MIR2911
was signiﬁcantly elevated (∼2.5-fold) in the fetuses (Fig. 1G),
suggesting that plant MIR2911 in HS can efﬁciently transfer
through the placenta to enter the fetal liver. Thus, plant
miRNAs in the diet can pass not only through mouse GI tract
to enter the maternal plasma but also through the placenta to
enter into the fetus, thereby inﬂuencing growth and devel-
opment. We next measured the amount of circulating
MIR2911 in MVs compared to that in MV-free plasma. After
gavage feeding, MIR2911 in MV-free plasma did not vary; in
contrast, MIR2911 was increased in MVs (Fig. 1H), sug-
gesting that circulating MIR2911 was primarily present in
MVs and that the transplacental transmission may involve an
MV-mediated pathway.
We then sought to explore whether double-stranded small
interfering RNA (siRNA) can transfer through the placenta.
First, a ﬂuorescently labelled siRNA was utilised to trace the
transplacental transmission of siRNA. The results showed
that the ﬂuorescent signal can be detected by confocal
microscopy in the fetal liver, suggesting that siRNA can pass
through the placenta and enter the fetal liver (Fig. 2A). Alpha-
fetoprotein (AFP) is a type of major plasma protein produced
in the yolk sac and the liver during fetal development. The
plasma level of AFP decreases rapidly after birth; thus, AFP
can be considered a protein that is speciﬁcally expressed
during fetal development. We then performed further ex-
periments to demonstrate that exogenous miRNAs in the fe-
tus have speciﬁc biological properties. A synthetic siRNA
targeting AFP mRNA was synthesised, and the interference
efﬁciency was veriﬁed in a mouse hepatocellular carcinoma
cell line (Hepa 1–6) (Fig. S1A). The mice were gavage fed
with the siRNAs at 2 nmol and 5 nmol, respectively. After 3 h,
the siRNA levels were signiﬁcantly elevated in the maternal
plasma and fetal liver in the 5 nmol group (Fig. 2B and 2C).
Interestingly, the mRNA and protein level of AFP was dra-
matically down-regulated in mice treated with 5 nmol siRNAs,
suggesting that exogenous siRNAs delivered from the mother
to the fetus by transplacental transmission, could regulate
fetal gene expression (Fig. 2D and 2E). Given that transpla-
cental transmission may involve an MV-mediated pathway,
we directly injected MVs loaded with siRNAs. The results
revealed that siRNA levels increased 2-fold in the fetus
(Fig. 2F) and that AFP mRNA levels were signiﬁcantly de-
creased (Fig. 2G). Taken together, these results suggested
that siRNAs can be delivered through the placenta and that
siRNAs have biological functions in the fetus.
The placenta is key to mammalian fetal development.
Many endogenous compounds can transfer through the
placenta. In addition to these compounds that are necessary
for fetal development, cells, viruses, and DNA can also pass
through the placenta. MiRNAs are a class of tiny molecules
with expansive functions in many pathological and physio-
logical process (Bartel, 2004). Because secreted miRNAs
packaged by MVs are stably present in the circulatory sys-
tem and are simultaneously transported to distant recipient
cells by MVs (Zhang et al., 2010), we believe that miRNAs
have great potential to be transferred through the placenta
by an MV-mediated mechanism. Given that exogenous plant
s
Figure 1. Small non-coding RNAs can transfer
through placenta and enter into fetuses. (A) The levels
(sequencing reads) of 6 plant miRNAs detected by Illumina
deep sequencing in umbilical cord blood and amniotic ﬂuid
from healthy pregnant women. (B) The Ct number of plant
miRNAs in mouse fetuses. (C) The concentrations and
relative levels of exogenous synthetic inﬂuenza virus
miRNAs in maternal plasma. (D) The concentrations and
relative levels of exogenous synthetic inﬂuenza virus
miRNAs in fetuses. (E) The concentrations and relative
levels of miR2911 in maternal plasma. (F) The concentra-
tions and relative levels of miR2911 in placentas. (G) The
concentrations and relative levels of miR2911 in fetal
livers. (H) The levels of MIR2911 in maternal plasma. Each
group n = 5, and all control groups were treated with the
equal volume saline.
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miRNAs can be absorbed by the GI tract and can regulate
gene expression across kingdoms (Zhang et al., 2012; Zhou
et al., 2015), exogenous plant miRNAs are believed to be
absorbed by the mother and transferred into the fetus.
This is the ﬁrst study to examine the transplacental
transmission of small-noncoding RNAs. The results revealed
that both single- and double-strand of small non-coding
RNAs can transfer through the placenta. Plant miRNAs are
the major source of exogenous RNAs for humans. Thus, it is
important to reveal whether natural miRNAs in plants can
pass through the placenta and regulate fetal development.
Our results revealed that MIR2911 from honeysuckle can be
absorbed and delivered into the fetal liver, suggesting that
not only the proteins, carbohydrates, and aliphatic acids but
also the nucleic acids in the maternal diet can be taken into
the fetus. It is mentionable that the majority of increased
MIR2911 was present in MVs, supporting that the transpla-
cental transmission of miRNAs is mediated by the MV
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Figure 2. The synthetic siRNA can pass through placenta and regulate gene expression in the fetal liver. (A) The confocal
microscopy photos of fetal liver after gavage fed with saline or ﬂuorescence-labeled siRNA. (B) The concentrations and relative levels
of siRNA in maternal plasma. (C) The concentrations and relative levels of siRNA in fetal livers. (D) The mRNA level of afp in fetal
livers. (E) The protein level of AFP in fetal livers. (F) The relative levels of siRNA in fetal liver after administration of siRNA by
intravenous injection. (G) The mRNA levels of afp in fetal livers after intravenous injection. Each group n = 5, and all control groups
were treated with the equal volume saline.
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pathway. Then, functional siRNAs for AFP were employed to
identify the effect of non-coding RNAs in the fetus; strikingly,
siRNAs ingested by maternal mice dramatically reduced the
AFP expression level. AFP is a critical protein in fetal de-
velopment. It has been demonstrated that AFP plays a role
in neuronal development because it serves as the binding
protein for arachidonic acid (AA) and docosahexaenoic acid
(DHA), which are important for neuronal development
(Mizejewski, 2004). Our ﬁndings demonstrate that mother-
derived miRNAs participate in fetal epigenetic regulation
during pregnancy, which may supply a new explanation for
some epigenetic phenomenon and congenital diseases.
Conventional wisdom holds that essential nutrients for fetal
development are carbohydrates, fats, dietary ﬁbre, minerals,
protein, vitamins, and water. Now, miRNAs should be another
nutrient. Given that maternal-fetal transplacental miRNAs play
an important role in fetal development, miRNA proﬁling of the
maternal diet is a new parameter that requires attention. The
dietary patterns of the mother will inﬂuence the fetus or even
determine the postnatal health status. Dietary bias or other
unhealthy dietary habits would also affect the fetal health by
disrupting the balance of transplacental miRNAs. Along the
same lines, the pathological status of the mother will result an
abnormal endogenous miRNA proﬁle per se, which will also
inﬂuence fetal health. Our ﬁndings also allow for the proposal
of a brand new strategy for disease treatment in utero. Ac-
cording to previous knowledge, various common viruses such
as human immunodeﬁciency virus (HIV), Rubella virus, hu-
man papillomavirus (HPV) and hepatitis C can be vertically
transmitted from the mother to the fetus (Atreya et al., 2004;
Castellsague et al., 2009; Le Campion et al., 2012; Soilleux
et al., 2001). The methods to treat these diseases remain
limited, and the maternal exposure to medicine may trigger
fetal DNA damage or may affect mitochondrial DNA (mtDNA)
(Brogly et al., 2011). Previous study demonstrated that mi-
crovesicles-mediated gene therapy is an ideal strategy to treat
various diseases (Li et al., 2013; Liu et al., 2013; van den
Boorn et al., 2011; Zhang et al., 2014). Our previous work also
reported that MIR2911, found in Chinese herbs, can be ab-
sorbed and accumulated in the lungs to inhibit the inﬂuenza A
virus (Zhou et al., 2015). Thus, gene therapy by administrating
virus-targeted artiﬁcial siRNA to the mother represents a new
trend for treat viruses in utero. The virus-targeted siRNA not
only treats the mother but also inhibits the virus from vertically
transmitting to the fetus.
In conclusion, the present study provides the ﬁrst evi-
dence that small non-coding RNA can be transplacentally
transmitted from the mother to the fetus. Although the data
suggest that transplacental transmission may be mediated
by MVs, further study must be performed to uncover the
mechanism of the transplacental transmission of small non-
coding RNA. Our data suggest another important parameter
for fetal development and health and a new potential disease
treatment in utero.
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